INSY

Insys Therapeutics, Inc.
INSY

Overview Fund Activity
Delisted

INSY was delisted on the 18th of June, 2019.

Back to rankings

145 hedge funds and large institutions have $1B invested in Insys Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 61 increasing their positions, 50 reducing their positions, and 24 closing their positions.

Holders
145
Holders Change
-1
Holders Change %
-0.68%
% of All Funds
4.05%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
24
Increased
61
Reduced
50
Closed
24
Calls
$32M
Puts
$73.8M
Net Calls
-$41.8M
Net Calls Change
-$13.2M

Top Buyers

1
O
1
OrbiMed
New York
$116M
2
SCM
2
Scopia Capital Management
New York
$48.9M
3
Citadel Advisors
3
Citadel Advisors
Florida
$27.5M
4
Wells Fargo
4
Wells Fargo
California
$23.9M
5
Goldman Sachs
5
Goldman Sachs
New York
$20.3M

Top Sellers

1
BTP
1
Bloom Tree Partners
New York
$0
2
Loomis, Sayles & Company
2
Loomis, Sayles & Company
Massachusetts
$11.4M
3
PP
3
PDT Partners
New York
$0
4
Two Sigma Investments
4
Two Sigma Investments
New York
$0
5
Allianz Asset Management
5
Allianz Asset Management
Germany
$238K
Name Market Value Shares Shares
Change 		Shares
Change %
MAM
176
Meeder Asset Management
Ohio
$0 7 +7 New
4 5 6 7
8